Dr. Kang is board-certified in internal medicine and gastroenterology. He has served on numerous National Institutes of Health panels. He was also appointed to the National Commission on Digestive Diseases in the Gastrointestinal Neoplasia section. He is currently the principal investigator on two investigator-initiated NIH grants. He previously served as associate editor of the American Journal of Gastroenterology.
Dr. Kang’s clinical interests include laser therapy, Barrett’s esophagus, esophageal cancer, photodynamic therapy, endoscopic ultrasonography, gastrointestinal bleeding and laser confocal microscopy.
Dr. Kang earned his medical degree at Wayne State University in Detroit and completed his residency and fellowship at Mayo Graduate School of Medicine/Mayo Clinic College of Medicine.
More articles on GI/endoscopy:
The latest advances in minimally invasive colorectal surgery
EndoChoice revenue leaps 27%: 5 things to know about Q2 financial results
55% of gastroenterologists will limit procedures for Medicare patients if colonoscopy cuts go into effect
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.